Guggenheim initiated coverage of Assembly Biosciences (ASMB) with a Buy rating and $31 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter